SEI Medical Co., Ltd. (SEI), a distributor of medical and scientific equipment, is ready to be traded on the Market for Alternative Investment (MAI) on September 24th with a market capitalization at the IPO price of 527 million baht, using the abbreviation “SEI” for trading.
Mr. Prapan Charoenprawat, Managing Director of the Market for Alternative Investment (mai), revealed that the mai welcomes SEI Medical Public Company Limited to list and start trading on mai under the Consumer Products Industry Group, using the abbreviation “SEI” on September 24, 2024. SEI operates its business as a distributor and service provider of medical equipment. The company sources medical and scientific equipment from 18 leading manufacturers from 11 countries.
he products are divided into 5 groups: Endoscope, Newborn, Beauty, Surgery, and Scientific Equipment and Tools. The target customers are government hospitals, medical education institutions, private hospitals, clinics, etc. In the first half of 2024, the company had revenue from sales, services, and others in the proportion of 90:10 respectively, of which 79 percent was from sales and services from government customers of total sales and services. The main product groups were: Endoscope product group 52 percent, product group for newborn patients 42 percent, and other product group 6 percent.
SEI has a paid-up capital after the offering of 85 million baht, with a par value of 0.50 baht per share, consisting of 120 million existing common shares and 50 million newly issued common shares, of which 37.50 million shares will be offered to persons at the discretion of the underwriter, 7.50 million shares will be offered to the company’s benefactors, and 5.00 million shares will be offered to directors, executives, and employees on September 16-18, 2024 at a price of 3.10 baht per share, for an IPO offering value of 155 million baht, with a securities value at the IPO price of 527 million baht.
The IPO offering price is determined by considering the price-to-earnings ratio (P/E Ratio) of 19.64 times, calculated from net profit over the past 12 months (from July 1, 2023 to June 30, 2023). 2567) divided by the number of common shares issued and paid after the offering of shares this time (fully diluted), resulting in net profit per share equal to 0.16 baht, with Avantgarde Capital Co., Ltd. as financial advisor and Yuanta Securities (Thailand) Co., Ltd. as underwriter and underwriter. Mr. Kan Punyacharoensin, Chief Executive Officer of SEI Medical Public Company Limited, revealed that throughout the past 30 years in the medical and scientific equipment industry, the company has focused on improving the quality of life and health of the population through innovation and cutting-edge technology.
The funds raised from the fundraising will be used as working capital to expand the business, including increasing potential and competitiveness, such as working capital to purchase medical equipment and devices, to expand the consumables business, and joint investment projects with other companies engaged in the medical business, which may include specialized clinics or hospitals. SEI After the IPO, major shareholders are Mr. Thira Punyacharoensin, holding 35.29 percent of shares, and Mr. Kan Punyacharoensin, holding 31.76 percent of shares. The company has a policy of paying dividends to shareholders at a rate of not less than 40 percent of net profit after tax and legal reserves. Investors and interested persons can see details from the company’s prospectus on the website of the SEC at www.sec.or.th and general information of the company www.sei.co.th and www.set.or.th
Source : MAI Stock Exchange welcomes SEI Medical PCL (SEI) to start trading on 24 September.
